Profits at Novartis Ireland down to €8.4m as firm raises research and development spend
Novartis Ireland is a significant employer in the healthcare industry here with over 1,000 employed in Dublin.
Accounts show revenues from the sale of goods declined from €139.86m to €137.55m while revenues from supply of business services decreased from €128.46m to €104.77m.
The directors state that revenues declining in pharma products sales were due to price and volume erosion of mature products.
Turnover relating to Novartis Corporate Centre (NOCC) services decreased by 18pc driven primarily by the reduction in functions related to Novartis's global initiative which launched in 2022 targeting a more focused pharmaceutical offering.
The company has a significant R&D arm in Ireland with numbers employed last year increasing from 224 to 270.
Last year, Novartis Ireland increased R&D spend from €26.4m to €34.9m.
And the company booked an R&D credit of €4.5m in the profit and loss account.
Overall numbers employed at Novartis Ireland Ltd reduced from 1,024 to 1,010 last year.
The company employed 663 in 'general and administration', 72 in marketing, sales and distribution and five in production and supply.
ADVERTISEMENT
Staff costs last year declined from €138.8m to €123.98m, that included €95.5m in wages and salaries and €4.7m in share-based payments.
Directors' pay increased from €992,000 to €1.35m made up of €1.27m in emoluments and €76,000 in pension contributions.
During the year, the company launched two new medicines aimed at treating cancer, Luxturna and Leqvio.
Under the heading of patient expiration and product competition, the directors state that 'the Irish Government continues to closely monitor pharmaceutical pricing and profitability, with pressure to control spending on HSE medicines'.
Shareholder funds totalled €88.8m, that included accumulated profits of €51.9m.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Independent
3 hours ago
- Irish Independent
Profits at Novartis Ireland down to €8.4m as firm raises research and development spend
New accounts filed by Novartis Ireland Ltd show the company recorded the drop in pre-tax profits as revenues declined by 10pc from €268.3m to €242.3m. Novartis Ireland is a significant employer in the healthcare industry here with over 1,000 employed in Dublin. Accounts show revenues from the sale of goods declined from €139.86m to €137.55m while revenues from supply of business services decreased from €128.46m to €104.77m. The directors state that revenues declining in pharma products sales were due to price and volume erosion of mature products. Turnover relating to Novartis Corporate Centre (NOCC) services decreased by 18pc driven primarily by the reduction in functions related to Novartis's global initiative which launched in 2022 targeting a more focused pharmaceutical offering. The company has a significant R&D arm in Ireland with numbers employed last year increasing from 224 to 270. Last year, Novartis Ireland increased R&D spend from €26.4m to €34.9m. And the company booked an R&D credit of €4.5m in the profit and loss account. Overall numbers employed at Novartis Ireland Ltd reduced from 1,024 to 1,010 last year. The company employed 663 in 'general and administration', 72 in marketing, sales and distribution and five in production and supply. ADVERTISEMENT Staff costs last year declined from €138.8m to €123.98m, that included €95.5m in wages and salaries and €4.7m in share-based payments. Directors' pay increased from €992,000 to €1.35m made up of €1.27m in emoluments and €76,000 in pension contributions. During the year, the company launched two new medicines aimed at treating cancer, Luxturna and Leqvio. Under the heading of patient expiration and product competition, the directors state that 'the Irish Government continues to closely monitor pharmaceutical pricing and profitability, with pressure to control spending on HSE medicines'. Shareholder funds totalled €88.8m, that included accumulated profits of €51.9m.
The Irish Sun
9 hours ago
- The Irish Sun
The bacterial infection you might catch while doing a hike – here's five signs to watch out for
THE HSE has issued a reminder over a bacterial infection caught outdoors that can lead to serious illness. Lyme disease is a condition that affects up to 400 people in Ireland each year. 3 Lyme disease is an illness caused by a bacteria following a bite from an infected tick Credit: Getty Images 3 The rash can appear up to three months after being bitten by a tick Credit: Getty Images 3 You can remove a tick safely using a fine-tipped tweezers or a tick-removal tool Credit: Getty Images Health chiefs have alerted the public to an infection that can be spread to humans by infected ticks. Most cases occur in the summer and autumn and it is easy to treat if it's diagnosed early. These are small brown bugs whose bite can cause Lyme disease. It is an illness caused by borrelia bacteria following a bite from an infected tick. Taking to X, formerly Twitter, they said: "#LymeDisease is a bacterial infection that can be spread to humans by infected ticks. "Most people with early symptoms of Lyme disease develop a circular red skin rash around a tick bite." The condition can affect anyone but is most common amongst those who spend time in grassy or heavily wooded areas or are in contact with certain animals like deer and sheep. Only a small number of individuals will develop Lyme disease following a tick bite. However, early identification of Lyme disease with prompt and appropriate antibiotic therapy is important to minimise the likelihood of the development of late stage infection. The rash can appear up to three months after being bitten by a tick and most rashes appear within the first four weeks. The major symptoms of 'common cancer' as HSE say 'know the signs' It usually lasts for several weeks and not everyone with the illness gets the rash. The rash can look like a bull's-eye on a dartboard, and the skin is usually red and the edges may feel slightly raised. MAJOR SYMPTOMS In the early stages you may also have flu-like symptoms such as: feeling hot and shivery, or a high temperature headaches muscle and joint pain tiredness and loss of energy Mood changes and anxiety. Health chiefs advise those bitten to remove ticks as soon as possible as Lyme disease can be prevented if infected ticks are removed within 36 hours. In Ireland, about five per cent of ticks are thought to carry Lyme disease bacteria. And high-risk areas can include sand dunes, grassy and wooded areas. HOW TO REMOVE TICKS Tick bites are not always painful. You may not notice a tick unless you see it on your skin. You should check your skin after being outdoors. Also check your children for ticks, especially their head and hairline. Pets can carry the ticks and need to be checked as well. Use fine-tipped tweezers or a tick-removal tool. You can buy these from some pharmacies, vets and pet shops. Here are three steps to removing a tick safely: Grasp the tick as close to the skin as possible. Slowly pull upwards, taking care not to squeeze or crush the tick - dispose of it carefully. Clean the bite with antiseptic or soap and water. Most people with Lyme disease get better after antibiotic treatment.
Irish Times
a day ago
- Irish Times
The Irish Times view on delayed hospital discharges: a perennial problem with serious consequences
The latest figures from the HSE show that there were delays in discharging 5,500 people from acute hospital care so far this year, leading to more than 85,500 lost 'bed days' in the system. In turn, this is contributing to delays in people getting through the A&E system and in particular more time spent on trolleys. And we know that, as well as causing discomfort, this also exposes the patients to higher clinical risk. What is formally called a delayed transfer of care occurs when a person is ready to leave the acute care system but remains occupying a bed. This is a perennial problem in the Irish hospital system and is part of a wider story of a growing and ageing population putting pressure on social services. This can happen for a number of reasons but generally involves older people who are waiting for an appropriate care programme at home, a bed in a step-down facility or space in a nursing home. Homelessness can be another issue. There has been some limited progress in recent years, with the 5,548 delayed patient transfers so far this year down from 6,6610 in 2023. But despite a range of action plans from successive ministers going back more than a decade, the issue remains a serious one. As well as contributing to the ongoing unacceptably high number of people on trolleys, an unnecessarily long stay in an acute ward also opens up the patient to greater risk of infection and means they are delayed getting on with their lives in a more appropriate setting. More funding for step-down facilities and home support packages will remain needed as the population ages. The lack of joined up technology in the Irish health system remains an issue. And delays in the administration of the support schemes for nursing homes - the Fair Deal scheme- and in the provision of home care packages are also factors. READ MORE Tackling delayed discharge remains a key issue for the hospital system . And it is also vital for the support and dignity of the largely older population and their families, who are seeking the best way forward after a period of hospital care.
